News | July 02, 2024
Abbott and YRGCARE inaugurate new outreach centers in India
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
The demand in Africa for COVID-19 vaccines has declined
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
Subscribe To Our Newsletter & Stay Updated
